Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children’s Oncology Group phase 1 consortium study - Mosse, Y P; Lim, M S; Voss, S D (The lancet oncology, 2013)
et al.